Zdrowie i gospodarka · 24/08/2005

FDA Extends Comment Period for Draft Guidance on Gingivitis Treatment Drugs

The US Food and Drug Administration (FDA) is extending the comment period for its draft guidance on developing and evaluating drugs for treating or preventing gingivitis until October 28, 2005, in response to a request from industry sponsors.